These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34372793)

  • 1. Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB/RIF.
    Seifert M; Aung HT; Besler N; Harris V; Mar TT; Colman RE; Rodwell TC; Aung ST
    BMC Infect Dis; 2021 Aug; 21(1):781. PubMed ID: 34372793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xpert
    Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study.
    van Kampen SC; Susanto NH; Simon S; Astiti SD; Chandra R; Burhan E; Farid MN; Chittenden K; Mustikawati DE; Alisjahbana B
    PLoS One; 2015; 10(6):e0123536. PubMed ID: 26075722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Accuracy of Xpert
    Feng JN; Gao L; Sun YX; Yang JC; Deng SW; Sun F; Zhan SY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):320-326. PubMed ID: 33879905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
    Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
    Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in pediatric tuberculosis diagnosis utilizing xpert
    Garba MA; Ogunbosi BO; Musa A; Ibraheem RM; Alao MA; Jiya-Chitumu EN; Olorukooba AA; Makarfi HU; Tahir Y; Ibrahim H; Saidu AA; Bashir MF; Odimegwu CL; Ayuk A; Alkali NH
    Int J Mycobacteriol; 2023; 12(1):77-81. PubMed ID: 36926767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
    Wasihun AG; Dejene TA; Hailu GG
    PLoS One; 2020; 15(11):e0240361. PubMed ID: 33147218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of GeneXpert
    Habous M; E Elimam MA; Kumar R; L Deesi ZA
    Int J Mycobacteriol; 2019; 8(2):132-137. PubMed ID: 31210154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021.
    Biset S; Teferi M; Alamirew H; Birhanu B; Dessie A; Aschale A; Haymanot A; Dejenie S; Gebremedhin T; Abebe W; Adane G
    BMC Infect Dis; 2024 Feb; 24(1):238. PubMed ID: 38389060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos Referral Hospital, Ethiopia: a cross-sectional study.
    Mulu W; Abera B; Yimer M; Hailu T; Ayele H; Abate D
    BMC Res Notes; 2017 Jan; 10(1):8. PubMed ID: 28057041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study.
    Huang H; Zhang Y; Li S; Wang J; Chen J; Pan Z; Gan H
    Microb Drug Resist; 2018 Jun; 24(5):675-679. PubMed ID: 29053085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
    Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
    Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
    Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Application of Xpert Mycobacterium tuberculosis/Rifampicin, Quantitative Polymerase Chain Reaction and High Resolution Melting Curve in the Diagnosis of Superficial Lymph Node TB.
    Han Y; Xiao N; Huang S; Qin M; Che N; Liu Z
    Curr Pharm Biotechnol; 2019; 20(12):1044-1054. PubMed ID: 31333119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.
    Tsuyuguchi K; Nagai H; Ogawa K; Matsumoto T; Morimoto K; Takaki A; Mitarai S
    J Infect Chemother; 2017 Feb; 23(2):101-106. PubMed ID: 27919693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Xpert MTB/RIF for detection of Mycobacterium tuberculosis and rifampicin resistance in pus aspirates.
    Set R; Bankar S; Sharma D; Shah D; Shastri J
    Indian J Tuberc; 2019 Oct; 66(4):433-436. PubMed ID: 31813428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.